Positional candidate genes for TAILWITHDRAWALLATENCYMEAN in BXD RI Males on Chr6
Description:
Position candidates for TAILWITHDRAWALLATENCYMEAN measured in BXD RI Males. TAILWITHDRAWALLATENCYMEAN measures Thermal Nociception Tail Withdrawal Test under the domain Pain. The QTL found was a Significant QTL and spans 112 Mb to 116 Mb.
Authors:
Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, Cook MN, Hamre KM, Lariviere WR, Matthews DB, Mittleman G, Goldowitz D, Chesler EJ
Positional candidate genes for TAILWITHDRAWALLATENCYMEAN in BXD RI Females & Males on Chr6
Description:
Position candidates for TAILWITHDRAWALLATENCYMEAN measured in BXD RI Females & Males. TAILWITHDRAWALLATENCYMEAN measures Thermal Nociception Tail Withdrawal Test under the domain Pain. The QTL found was a Significant QTL and spans 112 Mb to 116 Mb.
Authors:
Philip VM, Duvvuru S, Gomero B, Ansah TA, Blaha CD, Cook MN, Hamre KM, Lariviere WR, Matthews DB, Mittleman G, Goldowitz D, Chesler EJ
QTL for morphine preference on Chr6 at NA (1.89 Mbp , Build 37)
Description:
morphine preference spans 0.00 - 26.89 Mbp (NCBI Build 37) on Chr6. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
QTL for METH responses for home cage activity on Chr6 at Met (13.99 Mbp , Build 37)
Description:
METH responses for home cage activity spans 0.00 - 38.99 Mbp (NCBI Build 37) on Chr6. This interval was obtained by using an interval width of 25 Mbp around the peak marker (Build 37, MGI, http://informatics.jax.org).
QTL associated with bronchial hyperresponsiveness 5. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (115192871)
Authors:
Ackerman KG, Huang H, Grasemann H, Puma C, Singer JB, Hill AE, Lander E, Nadeau JH, Churchill GA, Drazen JM, Beier DR
QTL associated with cystic fibrosis body weight 2. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (111954645)
QTL associated with collagen induced arthritis QTL 3. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (113297319)
QTL associated with femoral cross-sectional area 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (88931018)
Authors:
Klein RF, Turner RJ, Skinner LD, Vartanian KA, Serang M, Carlos AS, Shea M, Belknap JK, Orwoll ES
QTL associated with gastritis type A susceptibility locus 3. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (105955399)
Authors:
Baxter AG, Jordan MA, Silveira PA, Wilson WE, Van Driel IR
QTL associated with immediate cutaneous hypersensitivity QTL. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (107745604)
Authors:
Daser A, Koetz K, Btjer N, Jung M, Rschendorf F, Goltz M, Ellerbrok H, Renz H, Walter J, Paulsen M
QTL associated with lung tumor shape-determining 8. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (126992874)
QTL associated with modifier of ocular retardation 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (124307332)
QTL associated with obesity and body weight QTL 3. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (107745604)
QTL associated with ovarian teratoma susceptibility 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (96605945)
Authors:
Lee GH, Bugni JM, Obata M, Nishimori H, Ogawa K, Drinkwater NR
QTL associated with plasma apolipoprotein B (human) regulator 1. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (114232092)
Authors:
Ko C, Lee TL, Lau PW, Li J, Davis BT, Voyiaziakis E, Allison DB, Chua SC Jr, Huang LS
QTL associated with pulmonary adenoma susceptibility 1c. This interval was obtained by using a fixed interval width of 25 Mbp around the peak marker (88931018)
Authors:
Festing MF, Lin L, Devereux TR, Gao F, Yang A, Anna CH, White CM, Malkinson AM, You M
GeneWeaver